The Code of Federal Regulations of the United States of AmericaU.S. Government Printing Office, 1990 The Code of Federal Regulations is the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government. |
No grāmatas satura
1.–5. rezultāts no 70.
3. lappuse
... Licensing .... 14 ........ 606 Current good manufacturing practice for blood and blood components ...... 27 607 Establishment registration and product listing for manufacturers of human blood and blood prod- ucts ............... 610 620 ...
... Licensing .... 14 ........ 606 Current good manufacturing practice for blood and blood components ...... 27 607 Establishment registration and product listing for manufacturers of human blood and blood prod- ucts ............... 610 620 ...
6. lappuse
... license for use upon each pack- age of the product . ( 1 ) " Dating period " means the period beyond which the product cannot be expected beyond reasonable doubt to yield its specific results . ( m ) " Expiration date " means the ...
... license for use upon each pack- age of the product . ( 1 ) " Dating period " means the period beyond which the product cannot be expected beyond reasonable doubt to yield its specific results . ( m ) " Expiration date " means the ...
12. lappuse
... licensed in vitro diagnostic products , and manu- facturers of unlicensed in vitro diag- nostic products which are required to be registered under Part 607 of this chapter , shall notify the Director in accordance with paragraph ( a ) ...
... licensed in vitro diagnostic products , and manu- facturers of unlicensed in vitro diag- nostic products which are required to be registered under Part 607 of this chapter , shall notify the Director in accordance with paragraph ( a ) ...
13. lappuse
... license , issued by the Director , Center for Bio- logics Evaluation and Research . [ 39 FR 39872 , Nov. 12 , 1974 ... license is pending need not be made until the establishment is in operation and is manufacturing the complete product ...
... license , issued by the Director , Center for Bio- logics Evaluation and Research . [ 39 FR 39872 , Nov. 12 , 1974 ... license is pending need not be made until the establishment is in operation and is manufacturing the complete product ...
14. lappuse
... license . 601.5 Revocation of license . 601.6 Suspension of license . 601.7 Procedure for hearings . 601.8 Publication of revocation . 601.9 Licenses ; reissuance . Subpart B - Establishment Licensing 601.10 Establishment licenses ...
... license . 601.5 Revocation of license . 601.6 Suspension of license . 601.7 Procedure for hearings . 601.8 Publication of revocation . 601.9 Licenses ; reissuance . Subpart B - Establishment Licensing 601.10 Establishment licenses ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
8800 Rockville Pike amended at 49 animals antibody antigen applicable biological product Biologics Evaluation Blood Group blood product cell cultures Center for Biologics container label cosmetic product Cryoprecipitated date of manufacture Department dilution Director donor dose Drug Administration effective date establishment Evaluation and Research Federal Food final container final product Food and Drug Globulin guinea pigs hepatitis B surface human ingredient injection inoculated introductory text least manufac measles virus ment metic mice milliliter monkeys mumps virus nomenclature change Office package label panel paragraph percent plasmapheresis Platelets Poliovirus Potency test prepared prescribed procedures prod proper name reagents red blood cells Reference requirements Rockville Pike rubella virus safety Schick Test serum Service source material Source Plasma statement sterile subchapter Subpart surface antigen tainer temperature tion tissue culture ture U.S. Standard unit virus pool Virus Vaccine Live Whole Blood
Populāri fragmenti
196. lappuse - ... (f) if any word, statement, or other information required by or under authority of this Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or graphic matter in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use...
200. lappuse - Warning — Contains a chlorofluorocarbon that may harm the public health and environment by reducing ozone in the upper atmosphere. (2) The warning required by paragraph (c)(1) of this section shall appear on an appropriate panel with such prominence and conspicuousness as to render it likely to be read and understood by ordinary individuals under normal conditions of purchase. The warning may appear on a firmly affixed §740.18 tag, tape, card, or sticker or similar over-labeling attached to the...
205. lappuse - National Academy of Sciences, National Research Council 2101 Constitution Ave. NW., Washington, DC 20037 Food...
188. lappuse - ... in terms of square inches or common or decimal fractions of the square foot or square yard; for example, "158 sq inches (1 sq ft 14 sq in).
x. lappuse - The total cost of my order is $_ International customers please add 25%. Please Type or Print (Company or personal name) (Additional address/attention line) (Street address) (City, State...
5. lappuse - ... and prepared at an establishment holding an unsuspended and unrevoked license, issued by the Secretary...
6. lappuse - State or possession, any virus, therapeutic serum, toxin, antitoxin, or analogous product, or arsphenamine or its derivatives (or any other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of diseases or injuries of man...
183. lappuse - ... is to be processed, labeled, or repacked; or (2) In case such person is not such operator, such shipment or delivery is made to such establishment under a written agreement, signed by and containing the post office addresses of such person and such operator, and containing such specifications for the processing, labeling, or repacking...
22. lappuse - Mar. 26, 1990] § 601.26 Reclassification procedures to determine that licensed biological products are safe, effective, and not misbranded under prescribed, recommended, or suggested conditions of use.
185. lappuse - Where a person manufactures, packs, or distributes a cosmetic at a place other than his principal place of business, the label may state the principal place of business in lieu of the actual place where...